BC
BPMC

BIT Capital’s Blueprint Medicines BPMC Stock Holding History

BIT Capital’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-75,000
Closed -$8.08M – 117
2024
Q2 		$8.08M Hold
75,000
– – 0.63% 29
2024
Q1 		$7.11M Buy
+75,000
New +$6.43M 0.53% 37

Other funds holding BPMC

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

BIT Capital's BPMC Position: Q3 2025 in Review

BIT Capital sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 1,423 shares — an estimated $182K sold.

BIT Capital first reported a position in BPMC in Q2 2023 and held it in 9 quarters. The position peaked at $16.6M in Q2 2024. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

  • BIT Capital reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
  • BIT Capital sold 1,423 Blueprint Medicines shares in Q3 2025, an estimated $182K.
  • BIT Capital first reported a position in Blueprint Medicines in Q2 2023 and held it in 9 quarters.
  • BIT Capital's Blueprint Medicines position peaked at $16.6M in Q2 2024.
  • 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on BIT Capital's 13F filing for Q3 2025, filed 10 Nov 2025.